News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,031 Results
Type
Article (52994)
Company Profile (402)
Press Release (605635)
Section
Business (188341)
Career Advice (2703)
Deals (34312)
Drug Delivery (105)
Drug Development (81862)
Employer Resources (166)
FDA (16548)
Job Trends (15461)
News (330009)
Policy (33030)
Tag
Academia (2859)
Alliances (47980)
Alzheimer's disease (1304)
Approvals (16458)
Artificial intelligence (146)
Bankruptcy (338)
Best Places to Work (11767)
Biotechnology (304)
Breast cancer (128)
Cancer (1155)
Cardiovascular disease (108)
Career advice (2275)
Cell therapy (258)
Clinical research (64879)
Collaboration (412)
Compensation (142)
COVID-19 (2775)
C-suite (103)
Data (1137)
Diabetes (163)
Diagnostics (6248)
Earnings (70656)
Employer resources (149)
Events (96082)
Executive appointments (316)
FDA (17097)
Funding (362)
Gene therapy (195)
GLP-1 (667)
Government (4657)
Healthcare (19238)
Infectious disease (2868)
Inflammatory bowel disease (119)
Interviews (504)
IPO (15491)
Job creations (4068)
Job search strategy (1910)
Layoffs (475)
Legal (7510)
Lung cancer (187)
Manufacturing (190)
Medical device (13203)
Medtech (13208)
Mergers & acquisitions (18891)
Metabolic disorders (453)
Neuroscience (1607)
NextGen Class of 2024 (6971)
Non-profit (4860)
Northern California (1445)
Obesity (259)
Opinion (225)
Patents (105)
People (55459)
Phase I (20201)
Phase II (28438)
Phase III (21535)
Pipeline (462)
Postmarket research (2601)
Preclinical (8369)
Radiopharmaceuticals (245)
Rare diseases (238)
Real estate (5813)
Regulatory (22244)
Research institute (2532)
Resumes & cover letters (415)
Southern California (1300)
Startups (3682)
United States (13197)
Vaccines (645)
Weight loss (206)
Date
Today (124)
Last 7 days (842)
Last 30 days (3748)
Last 365 days (35614)
2024 (32600)
2023 (39835)
2022 (50960)
2021 (55400)
2020 (54485)
2019 (47842)
2018 (36503)
2017 (33370)
2016 (32590)
2015 (37253)
2014 (29255)
2013 (24019)
2012 (25671)
2011 (26348)
2010 (23955)
Location
Africa (934)
Arizona (155)
Asia (39104)
Australia (6733)
California (3318)
Canada (1194)
China (250)
Colorado (150)
Connecticut (147)
Europe (89421)
Florida (431)
Georgia (115)
Illinois (352)
Indiana (198)
Kansas (98)
Maryland (582)
Massachusetts (2487)
Michigan (157)
Minnesota (272)
New Jersey (908)
New York (927)
North Carolina (757)
Northern California (1445)
Ohio (138)
Pennsylvania (777)
South America (1298)
Southern California (1300)
Texas (431)
Utah (95)
Washington State (357)
659,031 Results for "oncoarendi therapeutics sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Press Releases
Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A
October 1, 2024
·
7 min read
Press Releases
Acquisition of Ovizio Imaging Systems SA
October 17, 2024
·
1 min read
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
Press Releases
ChemoMetec makes offer to buy Ovizio Imaging Systems SA
September 23, 2024
·
1 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
Press Releases
BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD.
October 7, 2024
·
5 min read
Drug Development
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis of a Phase 3 study evaluating a booster dose of ARCT-154 , the world’s first approved self-amplifying messenger RNA (sa-mRNA) COVID-19 vaccine, compared to a conventional mRNA COVID-19 vaccine.
February 5, 2024
·
8 min read
Drug Development
OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21)
OSE Immunotherapeutics SA, presented a poster on preclinical data on its mRNA therapeutic platform for the treatment of inflammatory and autoimmune disorders at the Federation of Clinical Immunology Societies annual meeting held in San Francisco.
June 20, 2024
·
8 min read
1 of 65,904
Next
